Taxonomy Code 2080P0210X(2080p0210x)
Pediatric Nephrology Physician. Providers: 14
Pediatric Nephrology Physician Providers
| NPI | Name | Type | Address |
|---|---|---|---|
|
M.D. Cyril F Strife |
Individual |
3333 Burnet Ave Ml 7022 Cincinnati, OH |
|
|
MD Stuart Goldstein |
Individual |
3333 Burnett Ave Mlc 7022 Cincinnati, OH |
|
|
MD Elif Erkan |
Individual |
3333 Burnet Ave Cincinnati, OH |
|
|
M.D. Mark M Mitsnefes |
Individual |
3333 Burnet Ave Ml 7022 Cincinnati, OH |
|
|
M.D. Prasad Devarajan |
Individual |
3333 Burnet Ave Ml 7022 Cincinnati, OH |
|
|
M.D. Francisco X. Flores |
Individual |
3333 Burnet Ave Ml 7022 Cincinnati, OH |
|
|
M.D. Donna Jean Lynn Claes |
Individual |
3333 Burnet Ave. Ml 7022 Cincinnati, OH |
|
|
DR. MD Jean-philippe Roy |
Individual |
3333 Burnet Ave Cincinnati, OH |
|
|
M.D. Charles David Varnell JR. |
Individual |
3333 Burnet Ave # Mlc7022 Cincinnati, OH |
|
|
DR. M.D., M.S. David K Hooper |
Individual |
3333 Burnet Ave Mlc 7022 Cincinnati, OH |
|
|
DR. M.D. Meredith Posner Schuh |
Individual |
3333 Burnet Ave Ml 7022 Cincinnati, OH |
|
|
M.D., MPH Stefanie Woolridge Benoit |
Individual |
3333 Burnet Ave Mlc 7022 Cincinnati, OH |
|
|
M.D. MPH Meredith Harris |
Individual |
3333 Burnet Ave Ml 5018 Cincinnati, OH |
|
|
Hillarey Stone |
Individual |
3333 Burnet Ave., Ml 7022 Cincinnati, OH |
How to obtain, renew, or terminate an NPI
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
| Taxonomy Code | 2080P0210X |
| Specialization | Pediatric Nephrology |
| Display Name | Pediatric Nephrology Physician |
| Taxonomy Group | Allopathic & Osteopathic Physicians |
| Taxonomy Classification | Pediatrics |
| Definition | A pediatrician who deals with the normal and abnormal development and maturation of the kidney and urinary tract, the mechanisms by which the kidney can be damaged, the evaluation and treatment of renal diseases, fluid and electrolyte abnormalities, hypertension and renal replacement therapy. |
| Effective Date | September 30, 2009 |
| Modification Date | September 30, 2009 |